CN115097020B - Method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum - Google Patents
Method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum Download PDFInfo
- Publication number
- CN115097020B CN115097020B CN202210592242.9A CN202210592242A CN115097020B CN 115097020 B CN115097020 B CN 115097020B CN 202210592242 A CN202210592242 A CN 202210592242A CN 115097020 B CN115097020 B CN 115097020B
- Authority
- CN
- China
- Prior art keywords
- ethyl
- acetate
- gamma
- mass spectrum
- resolution mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001819 mass spectrum Methods 0.000 title claims abstract description 46
- 241000208125 Nicotiana Species 0.000 title claims abstract description 37
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 37
- 239000000796 flavoring agent Substances 0.000 title claims abstract description 33
- 235000019634 flavors Nutrition 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000012216 screening Methods 0.000 title claims abstract description 28
- 230000005686 electrostatic field Effects 0.000 title claims abstract description 21
- 239000002131 composite material Substances 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 33
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 14
- 235000013599 spices Nutrition 0.000 claims abstract description 5
- 150000002500 ions Chemical class 0.000 claims description 61
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 42
- 239000012634 fragment Substances 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims description 22
- 230000014759 maintenance of location Effects 0.000 claims description 20
- 239000000523 sample Substances 0.000 claims description 18
- 239000007789 gas Substances 0.000 claims description 17
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 claims description 16
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- 239000012086 standard solution Substances 0.000 claims description 14
- -1 dimethylsiloxane Chemical class 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- PPXUHEORWJQRHJ-UHFFFAOYSA-N ethyl isovalerate Chemical compound CCOC(=O)CC(C)C PPXUHEORWJQRHJ-UHFFFAOYSA-N 0.000 claims description 12
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims description 12
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 claims description 12
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 claims description 12
- 238000009826 distribution Methods 0.000 claims description 11
- GHBSPIPJMLAMEP-UHFFFAOYSA-N 6-pentyloxan-2-one Chemical compound CCCCCC1CCCC(=O)O1 GHBSPIPJMLAMEP-UHFFFAOYSA-N 0.000 claims description 10
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 claims description 10
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims description 10
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 claims description 10
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims description 10
- BYEVBITUADOIGY-UHFFFAOYSA-N ethyl nonanoate Chemical compound CCCCCCCCC(=O)OCC BYEVBITUADOIGY-UHFFFAOYSA-N 0.000 claims description 10
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 claims description 10
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 claims description 10
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 claims description 10
- PQLMXFQTAMDXIZ-UHFFFAOYSA-N isoamyl butyrate Chemical compound CCCC(=O)OCCC(C)C PQLMXFQTAMDXIZ-UHFFFAOYSA-N 0.000 claims description 10
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 claims description 10
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims description 10
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 claims description 10
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims description 8
- JLIDRDJNLAWIKT-UHFFFAOYSA-N 1,2-dimethyl-3h-benzo[e]indole Chemical compound C1=CC=CC2=C(C(=C(C)N3)C)C3=CC=C21 JLIDRDJNLAWIKT-UHFFFAOYSA-N 0.000 claims description 8
- OXQOBQJCDNLAPO-UHFFFAOYSA-N 2,3-Dimethylpyrazine Chemical compound CC1=NC=CN=C1C OXQOBQJCDNLAPO-UHFFFAOYSA-N 0.000 claims description 8
- LCZUOKDVTBMCMX-UHFFFAOYSA-N 2,5-Dimethylpyrazine Chemical compound CC1=CN=C(C)C=N1 LCZUOKDVTBMCMX-UHFFFAOYSA-N 0.000 claims description 8
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical compound CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 claims description 8
- DBZAKQWXICEWNW-UHFFFAOYSA-N 2-acetylpyrazine Chemical compound CC(=O)C1=CN=CC=N1 DBZAKQWXICEWNW-UHFFFAOYSA-N 0.000 claims description 8
- IGJQUJNPMOYEJY-UHFFFAOYSA-N 2-acetylpyrrole Chemical compound CC(=O)C1=CC=CN1 IGJQUJNPMOYEJY-UHFFFAOYSA-N 0.000 claims description 8
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 8
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 8
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 claims description 8
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 claims description 8
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 claims description 8
- DULCUDSUACXJJC-UHFFFAOYSA-N benzeneacetic acid ethyl ester Natural products CCOC(=O)CC1=CC=CC=C1 DULCUDSUACXJJC-UHFFFAOYSA-N 0.000 claims description 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 8
- IMKHDCBNRDRUEB-UHFFFAOYSA-N dihydroactinidiolide Chemical compound C1CCC(C)(C)C2=CC(=O)OC21C IMKHDCBNRDRUEB-UHFFFAOYSA-N 0.000 claims description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 8
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 8
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 8
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 8
- 229940043353 maltol Drugs 0.000 claims description 8
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 claims description 8
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 claims description 8
- 238000004896 high resolution mass spectrometry Methods 0.000 claims description 7
- 239000012488 sample solution Substances 0.000 claims description 7
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 claims description 6
- QOTQFLOTGBBMEX-UHFFFAOYSA-N alpha-angelica lactone Chemical compound CC1=CCC(=O)O1 QOTQFLOTGBBMEX-UHFFFAOYSA-N 0.000 claims description 6
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 claims description 6
- 239000001730 (5R)-5-butyloxolan-2-one Substances 0.000 claims description 5
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 claims description 5
- WGPCZPLRVAWXPW-NSHDSACASA-N 5-octyloxolan-2-one Chemical compound CCCCCCCC[C@H]1CCC(=O)O1 WGPCZPLRVAWXPW-NSHDSACASA-N 0.000 claims description 5
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 5
- CKOYRRWBOKMNRG-UHFFFAOYSA-N Furfuryl acetate Chemical compound CC(=O)OCC1=CC=CO1 CKOYRRWBOKMNRG-UHFFFAOYSA-N 0.000 claims description 5
- ZCZSIDMEHXZRLG-UHFFFAOYSA-N acetic acid heptyl ester Natural products CCCCCCCOC(C)=O ZCZSIDMEHXZRLG-UHFFFAOYSA-N 0.000 claims description 5
- VXHQWKIKXQTTEW-UHFFFAOYSA-N acetic acid;anisole Chemical compound CC(O)=O.COC1=CC=CC=C1 VXHQWKIKXQTTEW-UHFFFAOYSA-N 0.000 claims description 5
- 229940007550 benzyl acetate Drugs 0.000 claims description 5
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 claims description 5
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 claims description 5
- IFYYFLINQYPWGJ-VIFPVBQESA-N gamma-Decalactone Natural products CCCCCC[C@H]1CCC(=O)O1 IFYYFLINQYPWGJ-VIFPVBQESA-N 0.000 claims description 5
- WGPCZPLRVAWXPW-LLVKDONJSA-N gamma-Dodecalactone Natural products CCCCCCCC[C@@H]1CCC(=O)O1 WGPCZPLRVAWXPW-LLVKDONJSA-N 0.000 claims description 5
- IPBFYZQJXZJBFQ-UHFFFAOYSA-N gamma-octalactone Chemical compound CCCCC1CCC(=O)O1 IPBFYZQJXZJBFQ-UHFFFAOYSA-N 0.000 claims description 5
- JPXGPRBLTIYFQG-UHFFFAOYSA-N heptan-4-yl acetate Chemical compound CCCC(CCC)OC(C)=O JPXGPRBLTIYFQG-UHFFFAOYSA-N 0.000 claims description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 5
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims description 5
- 229940117955 isoamyl acetate Drugs 0.000 claims description 5
- 229940094941 isoamyl butyrate Drugs 0.000 claims description 5
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 claims description 5
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims description 5
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 claims description 5
- 229940095102 methyl benzoate Drugs 0.000 claims description 5
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 claims description 5
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims description 4
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 claims description 4
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims description 4
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 4
- 239000001674 (E)-1-(2,6,6-trimethyl-1-cyclohexenyl)but-2-en-1-one Substances 0.000 claims description 4
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 4
- BGTBFNDXYDYBEY-UHFFFAOYSA-N 1-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one Chemical compound CC=CC(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-UHFFFAOYSA-N 0.000 claims description 4
- 239000001934 2,5-dimethylpyrazine Substances 0.000 claims description 4
- AJKVQEKCUACUMD-UHFFFAOYSA-N 2-Acetylpyridine Chemical compound CC(=O)C1=CC=CC=N1 AJKVQEKCUACUMD-UHFFFAOYSA-N 0.000 claims description 4
- IEMMBWWQXVXBEU-UHFFFAOYSA-N 2-acetylfuran Chemical compound CC(=O)C1=CC=CO1 IEMMBWWQXVXBEU-UHFFFAOYSA-N 0.000 claims description 4
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 claims description 4
- GDNXVYSZGHBVNK-UHFFFAOYSA-N 4-butyloxetan-2-one Chemical compound CCCCC1CC(=O)O1 GDNXVYSZGHBVNK-UHFFFAOYSA-N 0.000 claims description 4
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 claims description 4
- 239000005711 Benzoic acid Substances 0.000 claims description 4
- 239000005973 Carvone Substances 0.000 claims description 4
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 4
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 4
- 239000005770 Eugenol Substances 0.000 claims description 4
- 230000005526 G1 to G0 transition Effects 0.000 claims description 4
- 239000005792 Geraniol Substances 0.000 claims description 4
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 4
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 claims description 4
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 claims description 4
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims description 4
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims description 4
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 4
- 235000010233 benzoic acid Nutrition 0.000 claims description 4
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 claims description 4
- IVLCENBZDYVJPA-ARJAWSKDSA-N cis-Jasmone Natural products C\C=C/CC1=C(C)CCC1=O IVLCENBZDYVJPA-ARJAWSKDSA-N 0.000 claims description 4
- 229940093503 ethyl maltol Drugs 0.000 claims description 4
- 229940073505 ethyl vanillin Drugs 0.000 claims description 4
- 229960002217 eugenol Drugs 0.000 claims description 4
- 229930002886 farnesol Natural products 0.000 claims description 4
- 229940043259 farnesol Drugs 0.000 claims description 4
- 238000004817 gas chromatography Methods 0.000 claims description 4
- 229940113087 geraniol Drugs 0.000 claims description 4
- 229930007744 linalool Natural products 0.000 claims description 4
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 claims description 4
- 229940116852 myricetin Drugs 0.000 claims description 4
- 235000007743 myricetin Nutrition 0.000 claims description 4
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims description 4
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 claims description 4
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 claims description 4
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 4
- 235000019260 propionic acid Nutrition 0.000 claims description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 4
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 claims description 4
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 claims description 4
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims description 4
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 3
- 239000012159 carrier gas Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- OALYTRUKMRCXNH-QMMMGPOBSA-N gamma-Nonalactone Natural products CCCCC[C@H]1CCC(=O)O1 OALYTRUKMRCXNH-QMMMGPOBSA-N 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000010200 validation analysis Methods 0.000 claims description 3
- ICMVGKQFVMTRLB-UHFFFAOYSA-N 4-phenylbutanenitrile Chemical compound N#CCCCC1=CC=CC=C1 ICMVGKQFVMTRLB-UHFFFAOYSA-N 0.000 claims description 2
- 238000012937 correction Methods 0.000 claims description 2
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 claims description 2
- 238000005070 sampling Methods 0.000 claims description 2
- OALYTRUKMRCXNH-UHFFFAOYSA-N 5-pentyloxolan-2-one Chemical compound CCCCCC1CCC(=O)O1 OALYTRUKMRCXNH-UHFFFAOYSA-N 0.000 claims 4
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 claims 2
- 229930007850 β-damascenone Natural products 0.000 claims 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 6
- 239000003205 fragrance Substances 0.000 description 11
- 238000001514 detection method Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 5
- ZIXLDMFVRPABBX-UHFFFAOYSA-N 2-methylcyclopentan-1-one Chemical compound CC1CCCC1=O ZIXLDMFVRPABBX-UHFFFAOYSA-N 0.000 description 4
- 241000662429 Fenerbahce Species 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 3
- 102100028292 Aladin Human genes 0.000 description 2
- 101710065039 Aladin Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VLSVVMPLPMNWBH-UHFFFAOYSA-N Dihydro-5-propyl-2(3H)-furanone Chemical compound CCCC1CCC(=O)O1 VLSVVMPLPMNWBH-UHFFFAOYSA-N 0.000 description 1
- 241001397104 Dima Species 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BGLUXFNVVSVEET-UHFFFAOYSA-N beta-angelica lactone Chemical compound CC1OC(=O)C=C1 BGLUXFNVVSVEET-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/16—Injection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/30—Control of physical parameters of the fluid carrier of temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/32—Control of physical parameters of the fluid carrier of pressure or speed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
- G01N30/6052—Construction of the column body
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7206—Mass spectrometers interfaced to gas chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
- G01N30/8686—Fingerprinting, e.g. without prior knowledge of the sample components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/32—Control of physical parameters of the fluid carrier of pressure or speed
- G01N2030/324—Control of physical parameters of the fluid carrier of pressure or speed speed, flow rate
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Library & Information Science (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention provides a method for screening and confirming a spice compound for cigarettes based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum, which comprises the following steps of (1) establishing a high-resolution mass spectrum database; (2) pretreatment of the composite tobacco flavor; (3) sample analysis; and (4) screening and confirming.
Description
Technical Field
The invention belongs to the field of analytical chemistry, and particularly relates to a method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrometry.
Background
In the cigarette production process, composite tobacco flavors such as a flavor base module and the like are required to be applied to tobacco leaves according to the type and style of cigarette products so as to improve the toughness and combustibility of the tobacco, improve the taste and increase the aroma. Therefore, the tobacco flavor compound plays a key role in flavoring the cigarettes, shaping the styles of the cigarettes, improving the fragrance quality of the cigarettes and improving the smoking quality. The key technology of cigarette flavoring is a weak link in scientific research work in the tobacco industry. The cigarette fragrance base module is formed by mixing and blending various natural fragrances and synthetic fragrances, and has complex components. The analysis research on the components of the tobacco flavor-based module is beneficial to analyzing the formula of complex essence and effectively controlling the quality of the essence and the spice, and has important significance in improving the research on the autonomous research and development of the tobacco essence and spice core technology, the self-guarantee capability and the replaceability.
The prior analysis and research on chemical components of the tobacco fragrance-based module mostly adopts a chromatograph-monopole mass spectrometer, but is limited by mass accuracy, sensitivity and dynamic linear range. For example, wei Weiwei uses gas chromatography-mass spectrometry, gas chromatography and chemometric data processing methods to analyze the natural perfume raw materials and part of the tobacco flavor components, and uses NIST02 spectrum library (low resolution mass spectrometry database) to retrieve qualitative properties, and accuracy is to be improved (middle and south university's master paper, 2010). Zhao Jian et al use a method of combining gas chromatography-mass spectrometry with autonomously developed software to analyze the components of essence with unknown components, and use an NIST02 spectrum library and a spectrum retention index in primary characterization; the qualitative results may change with a change in the set threshold in the smart software, resulting in overserved (oversubscription) or underserved (missed substances) (analytical science report, 2012,28, (2): 202-206.). Tandem mass spectrometry (e.g., triple quadrupole mass spectrometry) employs a multiple reaction detection mode (MRM) for targeted detection, which has strong quantitative capability, but has certain limitations in new component and unknown screening and validation. The electrostatic field orbit trap high-resolution mass spectrum (Orbitrap HRMS) has the advantages of high resolution and high quality precision, the acquired mass spectrum information is rich, comprehensive monitoring coverage can be achieved, and the method has remarkable advantages in screening and confirmation.
At present, no report of screening and confirming tobacco flavor, such as flavor module related substances, by adopting an electrostatic field orbit trap high-resolution mass spectrum is found. Therefore, it is necessary to develop a method for rapidly and accurately screening and confirming tobacco flavor (such as a flavor-based module) based on the high-resolution mass spectrum of the electrostatic field orbitrap, thereby creating necessary conditions for analyzing and effectively controlling the quality of the tobacco flavor.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrometry.
In order to solve the technical problems, the application adopts the following technical scheme:
a method for screening and confirming tobacco flavor compounds based on gas chromatography-quadrupole/electrostatic field orbitrap high-resolution mass spectrum comprises the following steps:
(1) Establishment of a high resolution mass spectrum database (Compounds database, CDB);
The mixed standard solution is measured by adopting gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrometry, and the retention time of the corresponding compound, the accurate molecular weight of fragment ions and the chemical formula information are obtained in a full scanning mode (FullScan); importing the data into TRACEFINDER to establish the high-resolution mass spectrum database;
(2) Pretreatment of the spice for the composite cigarette;
Accurately weighing the composite tobacco flavor to be measured, dissolving the composite tobacco flavor with ethanol, oscillating for 10-30 min at room temperature, taking 1mL of extract, and filtering the extract with a 0.22 mu m organic phase filter membrane into a chromatographic bottle to obtain a sample solution;
(3) Analyzing a sample;
Taking the sample solution obtained in the step (2), measuring under the same high-resolution mass spectrum conditions of gas chromatography-quadrupole/electrostatic field orbitrap as in the step (1), and collecting necessary data, wherein the data comprise retention time of each chromatographic peak, accurate molecular weight of fragment ions, isotope intensity and isotope distribution;
(4) Screening and validation
Introducing TRACEFINDER the data acquired in the step 3 into software, and automatically screening and matching with the information such as the retention time of the compound, the accurate mass number of fragment ions, the isotope intensity, the isotope distribution and the like in the high-resolution mass spectrum database established in the step 1; when the accurate mass number deviation of the target ion (TargetCompound) is smaller than 5 multiplied by 10 -6, the retention time deviation is smaller than 30s, the accurate mass number deviation of at least one confirmed ion (Confirming AND FRAGMENT) is smaller than 5 multiplied by 10 -6, and the isotope peak distribution is similar (theoretical and actual detection), judging to be detected; and comparing the secondary mass spectrogram of the detected component with a standard substance spectrogram recorded in a database, and confirming the detected component as the same substance.
Preferably, in the step (1), the conditions of the gas chromatography-quadrupole/electrostatic field orbitrap high resolution mass spectrum are:
Gas chromatography was tuned and calibrated using perfluorotributylamine;
Chromatographic column: elastic capillary column, specification: 60m×0.25mm×1.4 μm, stationary phase is 6% cyanopropylbenzene, 94% dimethylsiloxane; more preferably an Agilent DB-624 elastic capillary column;
carrier gas: helium with purity > 99.999%;
flow rate: 1.0mL/min;
Sample inlet temperature: 280 ℃;
Sample injection volume: 1 μl;
Sample injection mode: sampling in a split-flow mode;
split ratio: 10:1;
The temperature programming conditions of the column box are as follows: the initial temperature is 80 ℃ and kept for 1min, the temperature is raised to 100 ℃ at the speed of 4 ℃/min, kept for 5min, raised to 180 ℃ at the speed of 4 ℃/min, kept for 2min, raised to 230 ℃ at the speed of 4 ℃/min, and kept for 15min;
Transmission line temperature: 250 ℃;
Ionization mode: electron bombardment ionization (EI);
Ionization energy: 70ev;
Ion source temperature: 280 ℃;
Mass spectrometer scanning mode: full scan, 60000 resolution, scan mass number range 33-495; and using internal locking masses, correction was performed with fragment ions m/z 73.04680, m/z 133.0356, m/z 207.03235, m/z 281.05114, and m/z 355.06993.
Preferably, the mixed standard solution comprises a solvent selected from the group consisting of ethyl acetate, acetic acid, ethyl propionate, propionic acid, isoamyl alcohol, ethyl butyrate, butyric acid, ethyl isovalerate, isoamyl acetate, furfural, 2-methylbutyric acid, furfuryl alcohol, alpha-angelolide, 2, 5-dimethylpyrazine, 2, 3-dimethylpyrazine, 2-acetylfuran, butyl butyrate, furfuryl acetate, butyl acetate, 2,3, 5-trimethylpyrazine, D-limonene, isobutyl acetate, heptyl acetate, isoamyl butyrate, 2-acetylthiazole, 2-acetylpyrazine, 2-acetylpyridine, allyl caproate, methylcyclopentanone, benzyl alcohol, isoamyl isovalerate, 4-hydroxy-2, 5-dimethyl-3 (2H) furanone, linalyl acetate, methyl benzoate, 2-acetylpyrrole, gamma-caprolactone, phenethyl alcohol, maltol, benzyl acetate, ethyl benzoate, 2, 6-trimethyl-2-cyclohexen-1, 4-dione, 3-hydroxy-3, 5-dimethyl furanone, L-menthol, gamma-heptanolide, benzoic acid, ethyl maltol, ethyl phenylacetate, geraniol, ethyl pelargonate, ethyl phenylacetate, L-carvone, p-methoxybenzaldehyde, gamma-octalactone, linalool, nerol, eugenol, beta-damascone, methyl cinnamate, cis-jasmone, anisole acetate, gamma-nonenolactone, beta-ionone, alpha-ionone, myricetin, vanillin, ethyl cinnamate, nerolidol, ethyl vanillin, gamma-decalactone, farnesol, delta-decalactone, dihydroactinolide, raspberry ketone, methyl dihydrojasmonate, and gamma-dodecalactone.
More preferably, the mixed standard solution comprises ethyl acetate, acetic acid, ethyl propionate, propionic acid, isoamyl alcohol, ethyl butyrate, butyric acid, ethyl isovalerate, isoamyl acetate, furfural, 2-methylbutyric acid, furfuryl alcohol, alpha-angelolide, 2, 5-dimethylpyrazine, 2, 3-dimethylpyrazine, 2-acetylfuran, butyl butyrate, furfuryl acetate, butyl acetate, 2,3, 5-trimethylpyrazine, D-limonene, isobutyl acetate, heptyl acetate, isoamyl butyrate, 2-acetylthiazole, 2-acetylpyrazine, 2-acetylpyridine, allyl caproate, methylcyclopentanone, benzyl alcohol, isoamyl isovalerate, 4-hydroxy-2, 5-dimethyl-3 (2H) furanone, linalyl acetate, methyl benzoate, 2-acetylpyrrole, gamma-caprolactone, phenethyl alcohol, maltol, benzyl acetate, ethyl benzoate, 2, 6-trimethyl-2-cyclohexen-1, 4-dione, 3-hydroxy-3, 5-dimethyl furanone, L-menthol, gamma-heptanolide, benzoic acid, ethyl maltol, ethyl phenylacetate, geraniol, ethyl pelargonate, ethyl phenylacetate, L-carvone, p-methoxybenzaldehyde, gamma-octalactone, linalool, nerol eugenol, beta-damascone, methyl cinnamate, cis-jasmone, anisole acetate, gamma-nonolactone beta-ionone, alpha-ionone, myricetin, vanillin, ethyl cinnamate, nerolidol, all of ethyl vanillin, gamma-decalactone, farnesol, delta-decalactone, dihydroactinolide, raspberry ketone, methyl dihydrojasmonate, and gamma-dodecalactone.
Preferably, the TRACEFINDER software version is 4.1 and above.
Preferably, the high resolution mass spectrometry database includes information of compound name, CAS registration number, molecular formula, retention time, exact mass of Target Ion (Target Ion), and exact mass of three confirmed ions (Confirming Fragment).
Preferably, under the condition of the gas chromatography-quadrupole/electrostatic field orbitrap high-resolution mass spectrum, the high-resolution mass spectrum database is built as follows:
preferably, in the step (2), the sample weighing amount of the composite tobacco flavor is 500+/-25 mg.
Preferably, in the step (2), the mass ratio of the volume of ethanol to the composite tobacco flavor is: 50 ml/1 g.
Preferably, the composite tobacco flavor is a tobacco flavor-based module.
In the specification of the application, the ethanol is ethanol with the volume percentage concentration of 95-100 percent unless specified otherwise.
The invention utilizes the combination of ultra-high resolution, stable mass precision and high sensitivity of gas chromatography-quadrupole/electrostatic field orbit trap mass spectrum and TRACEFINDER software to establish an accurate mass database of the composite tobacco flavor, in particular to tobacco flavor base module related substances. The accurate mass number of the compound is combined with the information such as retention time, isotope intensity, isotope distribution and the like, and a threshold value is not required to be set, so that the sample can be rapidly screened. Compared with the prior art, the invention has the advantages of high detection speed, high detection efficiency, multiple analysis components and accurate screening result, and only needs 70-90min from the preparation of the sample solution to the completion of screening and confirmation of a cigarette fragrance base module, thereby providing a new technical support for high-throughput screening of relevant product additives.
Drawings
The invention is further described below with reference to the accompanying drawings.
FIG. 1 shows the correlation patterns obtained from different chromatographic columns. Wherein A: is a chromatogram of the mixed standard solution under the DB-5MS chromatographic column; b: a mass spectrum of the mixed standard solution under the DB-5MS chromatographic column; c: is a chromatogram of the mixed standard solution under the DB-624 chromatographic column; d: is a mass spectrum of the mixed standard solution under the DB-624 chromatographic column.
FIG. 2 is a graph showing the separation effect of standard compounds at different temperature elevation procedures.
FIG. 3 shows the results of screening D-limonene in the samples. Wherein, the upper graph shows a list of compound identification results based on fragment ions (. + -.5 ppm range), and the lower left graph shows an extracted ion chromatogram of D-limonene; the lower right panel is a secondary mass spectrum (upper and lower mass spectra show measured and theoretical fragment ions, respectively).
FIG. 4 shows the results of screening for alpha-angelicalactone. Wherein, the upper graph shows a compound identification result list based on fragment ions (±5ppm range), and the lower left graph shows an extraction ion chromatogram of alpha-angelica lactone; the lower right panel is a secondary mass spectrum (upper and lower mass spectra show measured and theoretical fragment ions, respectively).
FIG. 5 shows the results of screening maltol. Wherein, the upper graph shows a list of compound identification results based on fragment ions (±5ppm range), and the lower left graph shows an extracted ion chromatogram of maltol; the lower right panel is a secondary mass spectrum (upper and lower mass spectra show measured and theoretical fragment ions, respectively).
FIG. 6 shows the results of screening D, L-menthol. Wherein, the upper graph shows a list of compound identification results based on fragment ions (. + -.5 ppm range), and the lower left graph shows an extracted ion chromatogram of D, L-menthol; the lower right panel is a secondary mass spectrum (upper and lower mass spectra show measured and theoretical fragment ions, respectively).
FIG. 7 shows the results of screening for alpha-ionone. Wherein, the upper graph shows a list of compound identification results based on fragment ions (±5ppm range), and the lower left graph shows an extracted ion chromatogram of α -ionone; the lower right panel is a secondary mass spectrum (upper and lower mass spectra show measured and theoretical fragment ions, respectively).
FIG. 8 is a screening result of dihydroactinide. Wherein, the upper graph shows a compound identification result list based on fragment ions (within + -5 ppm), and the lower left graph shows an extraction ion chromatogram of dihydroactinolide; the lower right image is a secondary mass spectrogram, and the upper and lower mass spectrograms respectively show measured fragment ions and theoretical fragment ions.
Detailed Description
The invention is described below with reference to specific examples. It will be appreciated by those skilled in the art that these examples are for illustration of the invention only and are not intended to limit the scope of the invention in any way.
The experimental methods in the following examples are conventional methods unless otherwise specified. The raw materials, reagent materials and the like used in the examples described below are commercially available products unless otherwise specified. Wherein, partial reagent and instrument purchase conditions are as follows:
ThermoScientic TMTRACETM 1310 gas chromatograph, quadrupole/electrostatic field orbitrap high resolution mass spectrum Q-Exactive, thermoScientic TMTriPlusTM RSH autosampler: thermo Fisher company;
TRACEFINDER 4.1.1 software (database with unknown retrieval function and high resolution and accurate quality of common pollutants) is used for data processing;
AlphA-Angelicalactone (purity >98%, TCI); gamma valerolactone standard (purity 98%, alfa); gamma-caprolactone standard (purity 98%, alfa); gamma-heptanolactone standard (purity 98%, aletin); gamma-octalactone standard (purity >99%, adamas); gamma-nonanolactone standard (purity >97%, SIGMA-ALDRICH); gamma-decalactone (purity 98%, alfa); delta-decalactone (purity >97.0%, TCI); gamma-dodecalactone (purity 98%, SIGMA); dihydroactinolide (purity 98%, BLOCK chemistry); ethyl acetate (99.8% pure, SIGMA); butyl acetate (purity 99.7%, aladin); hexyl acetate (purity >99.5%, aladin); isobutyl acetate (purity >99.0%, TCI); isoamyl acetate (purity >98.0%, TCI); heptyl acetate (purity >99%, aletin); anisole acetate (purity 98%, aledine); benzyl acetate (99% pure, aletin); furfuryl acetate (99% pure, aledine); geranyl acetate (purity 98%, alfa); leaf alcohol acetate (purity 99%, alfa); linalyl acetate (purity >98%, adamas); neryl acetate (purity >95%, TCI); phenethyl acetate (purity 98%, aledine); ethyl propionate (99% purity, enoKai); butyl butyrate (purity >99%, aledine); ethyl butyrate (purity 99%, enoKai); isoamyl butyrate (99% pure, aletin); ethyl isovalerate (99% pure, aledine); isoamyl isovalerate (98% purity, aletin); allyl caproate (purity 98%, aletin); ethyl pelargonate (purity >99%, adamas); methyl benzoate (99% purity, enoKai); ethyl benzoate (purity >99%, enokie); methyl dihydrojasmonate (96% purity, aledine); methyl cinnamate (purity 99%, alfa); ethyl cinnamate (99% purity, adamas); d-limonene (purity >99%, TCI); ethanol (chromatographic purity, DIMA):
a tobacco fragrance base module: is provided by the technical center of certain national smoke industry company.
The mixed standard solutions used in the following study and/or examples were prepared by the following methods:
The standard substance is dissolved in ethanol to prepare a single standard substance standard stock solution, and the concentration is generally 0.5-2mg/mL. Then, the standard stock solution of the single standard product with different volumes is removed in a 10mL volumetric flask, and ethanol is used for fixing the volume, so that the mixed standard solution with the concentration of each standard product of 1 mug/mL is obtained.
Study example 1 optimization of chromatographic conditions
1. Optimization selection of gas chromatographic column:
First, a chromatographic column was optimized with a part of ester compounds (ethyl acetate, ethyl propionate, ethyl butyrate, ethyl isovalerate, etc.) as representative compounds.
Gas chromatography conditions:
Chromatographic column: DB-5MS chromatographic column, stationary phase is 5% -phenyl-methyl polysiloxane (30 m x 0.25mm x 1.0 μm) and DB-624 chromatographic column, stationary phase is 6% cyanopropyl benzene-methyl polysiloxane (60 m x 0.25mm x 1.4 μm);
carrier gas: helium with purity > 99.999%;
flow rate: 1.0mL/min;
Sample inlet temperature: 280 ℃;
Sample injection volume: 1 μl;
Sample injection mode: sample injection in a non-split mode;
The temperature programming conditions of the column box are as follows: the initial temperature is 40 ℃, and is kept for 2min, the temperature is increased to 180 ℃ at the speed of 5 ℃/min, the temperature is kept for 5min, the temperature is increased to 280 ℃ at the speed of 40 ℃/min, and the temperature is kept for 1min;
Transmission line temperature: 280 ℃;
Ionization mode: electron bombardment ionization (EI);
Ionization energy: 70ev;
Ion source temperature: 280 ℃;
Mass spectrum mass analyzer: quadrupole rods;
Mass spectrometer scanning mode: full scan, scan range m/z 30-350.
The related map is shown in figure 1.
As shown in a diagram in fig. 1, when using a DB-5MS column, characteristic ion (m/z 43, 29 and 61) chromatographic peaks of ethyl acetate were not observed at the same time in the chromatogram of the selected ion, characteristic fragment ion (m/z 29) of ethyl acetate was not observed in the B diagram, and the ratio of fragment ion to intensity observed in the mass spectrum was also different from the D diagram in fig. 1 and the standard mass spectrum of ethyl acetate, indicating that ethyl acetate was not detected, ethyl acetate and solvent (ethanol) were eluted together in the mixed standard solution. Therefore, the analysis purpose cannot be achieved by using a DB-5MS chromatographic column. Probably because the boiling point of ethyl acetate is 77℃and is close to that of ethanol (78 ℃), co-elution is caused. When using the DB-624 column, the chromatographic peaks (C plot in FIG. 1) of three characteristic ions (m/z 43, 29 and 61) of ethyl acetate were observed at the same time, and the corresponding mass spectrum (see D plot in FIG. 1) was also consistent with the standard mass spectrum of ethyl acetate. All targets can be well separated within 55 min. Thus, DB-624 chromatographic columns are preferred in the present invention.
2. Optimizing temperature programming conditions
The influence of three temperature programming conditions on the separation effect was examined under the above chromatographic conditions (except the temperature programming conditions) using a DB-624 column:
Program 1: the initial temperature is 80 ℃, and is kept for 1min, the temperature is increased to 180 ℃ at the speed of 4 ℃/min, the temperature is kept for 5min, the temperature is increased to 230 ℃ at the speed of 4 ℃/min, and the temperature is kept for 10min;
Program 2: the initial temperature is 80 ℃ and kept for 1min, the temperature is raised to 120 ℃ at the speed of 4 ℃/min, kept for 5min, raised to 180 ℃ at the speed of 4 ℃/min, kept for 2min, raised to 230 ℃ at the speed of 4 ℃/min, and kept for 15min;
Program 3: the initial temperature was 80℃and maintained for 1min, at a rate of 4℃per minute to 100℃and for 5min, at a rate of 4℃per minute to 180℃and for 2min, at a rate of 4℃per minute to 230℃and for 15min.
The chromatogram is shown in FIG. 2.
As can be seen from the circled portion of fig. 2, none of these standard compounds achieved baseline separation using temperature elevation procedure 1 and 2, and only temperature elevation procedure 3 achieved baseline separation of the compounds. Therefore, the temperature increase program 3 is preferable in the present invention.
Example 1 high resolution database was built based on gas chromatography-quadrupole/electrostatic field orbitrap high resolution mass spectrometry
The chromatographic conditions (chromatographic column and temperature-raising program) selected in research example 1 are adopted, 1 mu L of mixed standard solution is taken for sample injection, and the retention time of the corresponding compound, the accurate molecular weight of fragment ions, the chemical formula and other spectrogram information are obtained in a full scanning mode (FullScan). 4 fragment ions were selected for each compound to obtain ion information (exact mass, chemical formula). The data is imported TRACEFINDER to build a relational database as shown in table 1.
Table 1 high resolution mass spectrum database information for 76 standard compounds
/>
/>
Example 2 screening and confirmation of tobacco fragrance module related Compounds
1. Pretreatment of cigarette fragrance base module
Accurately weighing 511.6mg of cigarette fragrance base module, placing in a triangular flask, adding 25mL of ethanol solution, oscillating at room temperature for 20min, collecting 1mL of extractive solution, filtering with 0.22 μm organic phase filter membrane, and bottling to obtain sample solution
2. Sample analysis
Under the same chromatographic-mass spectrometry conditions as in example 1, 1 μl of the sample solution is sampled, and the chromatograms are recorded to obtain information such as retention time, accurate fragment ion mass number, isotope intensity and isotope distribution of each compound.
3. Screening and confirmation of Compounds
The data obtained in the previous step are imported into TRACEFINDER software, and are automatically screened and matched with the information such as the retention time of the compounds, the accurate mass number of fragment ions, the isotope intensity, the isotope distribution and the like in the database established in the embodiment 1. When the Target Compound (Target Compound) accurate mass number deviation is smaller than 5×10 -6, the retention time deviation is smaller than 30s, the accurate mass number deviation of at least one confirmed ion (Confirming AND FRAGMENT) is smaller than 5×10 -6, and the isotope peak distribution is similar (theoretical and actual detection) as detected. The secondary mass spectrogram of the detected component is consistent with the spectrogram of the standard substance recorded in the database, and can be confirmed to be the same substance.
The compounds of the present invention such as α -angelic lactone, D-limonene, maltol, D, L-menthol, α -ionone, and dihydroactinolide in table 1 were detected in the samples of the cigarette fragrance base module measured in this example. Taking D-limonene as an example for the screening and confirming process of the method: the corresponding ion extraction ion flow diagram, primary mass spectrum and secondary mass spectrum of the target ions in the sample are shown in figure 3. In the database, the retention time of D-limonene was 21.768min, theoretical target ion m/z 93.06988, corroborating ions m/z 79.05423, 91.05423 and 67.05423; the retention time of suspicious peaks in the target ion extraction ion flow graph is 21.78min, which is consistent with the retention time recorded in the database, and meets the requirement of the retention time. The range of the accurate mass number of the extracted ions in the primary mass spectrogram is 93.06941-93.07035, and compared with a theoretical value, the mass deviation meets the requirement of 5ppm and meets the requirement of the mass number of the target ions. The secondary mass spectrogram has consistent characteristic fragment ions, and the overall distribution trend of the ions is consistent, so that the D-limonene can be confirmed.
Based on the same process, the determination of the compounds of alpha-angelicalactone, maltol, D, L-menthol, alpha-ionone, dihydroactinolide and the like in the sample is detected and confirmed; the results of screening for these compounds are shown in FIGS. 4-8.
While the preferred embodiments and examples of the present invention have been disclosed in connection with the accompanying drawings, the present invention is not limited to the above embodiments and examples, and modifications and improvements may be made by those skilled in the art without departing from the spirit and scope of the invention. The scope of the invention is therefore defined by the appended claims.
Claims (12)
1. A method for screening and confirming tobacco flavor compounds based on gas chromatography-quadrupole/electrostatic field orbitrap high-resolution mass spectrum comprises the following steps:
(1) Establishing a high-resolution mass spectrum database;
The mixed standard solution is measured by adopting gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrometry, and the retention time of the corresponding compound, the accurate molecular weight of fragment ions and the chemical formula information are obtained in a full scanning mode; importing the data into TRACEFINDER to establish the high-resolution mass spectrum database;
(2) Pretreatment of the spice for the composite cigarette;
Accurately weighing the composite tobacco flavor to be measured, dissolving the composite tobacco flavor with ethanol, oscillating for 10-30 min at room temperature, taking 1mL of extract, and filtering the extract with a 0.22 mu m organic phase filter membrane into a chromatographic bottle to obtain a sample solution;
(3) Analyzing a sample;
Taking the sample solution obtained in the step (2), measuring under the same high-resolution mass spectrum conditions of gas chromatography-quadrupole/electrostatic field orbitrap as in the step (1), and collecting necessary data, wherein the data comprise retention time of each chromatographic peak, accurate molecular weight of fragment ions, isotope intensity and isotope distribution;
(4) Screening and validation
Introducing TRACEFINDER the data acquired in the step 3 into software, and automatically screening and matching with the information such as the retention time of the compound, the accurate mass number of fragment ions, the isotope intensity, the isotope distribution and the like in the high-resolution mass spectrum database established in the step 1; when the accurate mass number deviation of the target ion is smaller than 5 multiplied by 10 -6, the retention time deviation is smaller than 30s, at least one confirmed ion accurate mass number deviation is smaller than 5 multiplied by 10 -6, and the isotope peak distribution is similar, judging to be detected; and comparing the secondary mass spectrogram of the detected component with a standard substance spectrogram recorded in a database, and confirming the detected component as the same substance.
2. The method according to claim 1, wherein in the step (1), the conditions of the gas chromatograph-quadrupole/electrostatic field orbitrap high resolution mass spectrum are:
Gas chromatography was tuned and calibrated using perfluorotributylamine;
chromatographic column: elastic capillary column, specification: 60m×0.25mm×1.4 μm, stationary phase is 6% cyanopropylbenzene, 94% dimethylsiloxane;
carrier gas: helium with purity > 99.999%;
flow rate: 1.0mL/min;
Sample inlet temperature: 280 ℃;
Sample injection volume: 1 μl;
Sample injection mode: sampling in a split-flow mode;
split ratio: 10:1;
The temperature programming conditions of the column box are as follows: the initial temperature is 80 ℃ and kept for 1min, the temperature is raised to 100 ℃ at the speed of 4 ℃/min, kept for 5min, raised to 180 ℃ at the speed of 4 ℃/min, kept for 2min, raised to 230 ℃ at the speed of 4 ℃/min, and kept for 15min;
Transmission line temperature: 250 ℃;
ionization mode: electron bombardment ionization;
Ionization energy: 70ev;
Ion source temperature: 280 ℃;
Mass spectrometer scanning mode: full scan, 60000 resolution, scan mass number range 33-495; and using internal locking masses, correction was performed with fragment ions m/z 73.04680, m/z 133.0356, m/z 207.03235, m/z 281.05114, and m/z 355.06993.
3. The method of claim 2, wherein the chromatographic column is an Agilent DB-624 elastic capillary column.
4. The method of claim 1, wherein the mixed standard solution comprises a solvent selected from the group consisting of ethyl acetate, acetic acid, ethyl propionate, propionic acid, isoamyl alcohol, ethyl butyrate, butyric acid, ethyl isovalerate, isoamyl acetate, furfural, 2-methylbutyric acid, furfuryl alcohol, alpha-angelica lactone, 2, 5-dimethylpyrazine, 2, 3-dimethylpyrazine, 2-acetylfuran, butyl butyrate, furfuryl acetate, butyl acetate, 2,3, 5-trimethylpyrazine, D-limonene, isobutyl acetate, heptyl acetate, isoamyl butyrate, 2-acetylthiazole, 2-acetylpyrazine, 2-acetylpyridine, allyl caproate, methylcycloenolone, benzyl alcohol, isoamyl isovalerate, 4-hydroxy-2, 5-dimethyl-3 (2H) furanone, linalyl acetate, methyl benzoate, 2-acetylpyrrole, gamma-caprolactone, phenethyl alcohol, maltol, benzyl acetate, ethyl benzoate, 2, 6-trimethyl-2-cyclohexen-4-2, 4-dihydroxy-3-2H) furanone, L-menthol, gamma-heptanolide, benzoic acid, ethyl maltol, ethyl phenylacetate, geraniol, ethyl pelargonate, ethyl phenylacetate, L-carvone, p-methoxybenzaldehyde, gamma-octalactone, linalool, nerol, eugenol, beta-damascone, damascenone, methyl cinnamate, cis-jasmone, anisole acetate, gamma-nonalactone, beta-ionone, alpha-ionone, myricetin, vanillin, ethyl cinnamate, nerolidol, ethyl vanillin, gamma-decalactone, farnesol, delta-decalactone, dihydroactinolide, raspberry ketone, methyl dihydrojasmonate, and gamma-dodecalactone.
5. The method of claim 4, wherein the mixed standard solution comprises ethyl acetate, acetic acid, ethyl propionate, propionic acid, isoamyl alcohol, ethyl butyrate, butyric acid, ethyl isovalerate, isoamyl acetate, furfural, 2-methylbutyric acid, furfuryl alcohol, alpha-angelica lactone, 2, 5-dimethylpyrazine, 2, 3-dimethylpyrazine, 2-acetylfuran, butyl butyrate, furfuryl acetate, butyl acetate, 2,3, 5-trimethylpyrazine, D-limonene, isobutyl acetate, heptyl acetate, isoamyl butyrate, 2-acetylthiazole, 2-acetylpyrazine, 2-acetylpyridine, allyl caproate, methylcycloenolone, benzyl alcohol, isoamyl isovalerate, 4-hydroxy-2, 5-dimethyl-3 (2H) furanone, linalyl acetate, methyl benzoate, 2-acetylpyrrole, gamma-caprolactone, phenethyl alcohol, maltol, benzyl acetate, ethyl benzoate, 2, 6-trimethyl-2-cyclohexen-4-2, 4-dihydroxy-3 (2H) furanone, L-menthol, gamma-heptanolide, benzoic acid, ethyl maltol, ethyl phenylacetate, geraniol, ethyl pelargonate, ethyl phenylacetate, L-carvone, p-methoxybenzaldehyde, gamma-octalactone, linalool, nerol, eugenol, beta-damascone, damascenone, methyl cinnamate, cis-jasmone, anisole acetate, gamma-nonalactone, beta-ionone, alpha-ionone, all of myricetin, vanillin, ethyl cinnamate, nerolidol, ethyl vanillin, gamma-decalactone, farnesol, delta-decalactone, dihydroactinolide, raspberry ketone, methyl dihydrojasmonate, and gamma-dodecalactone.
6. The method of claim 1, wherein the TRACEFINDER software release is 4.1 and above.
7. The method of claim 1, wherein the high resolution mass spectrometry database comprises information of compound name, CAS registry number, molecular formula, retention time, target ion exact mass, and three confirmed ion exact masses.
8. A method according to any one of claims 1 to 3, wherein the high resolution mass spectrum database is established under the conditions of the gas chromatograph-quadrupole/electrostatic field orbitrap high resolution mass spectrum as follows:
9. the method of claim 1, wherein in step (2), the composite tobacco flavor is weighed in an amount of 500±25mg.
10. The method according to claim 1 or 9, wherein in the step (2), the mass ratio of the volume of ethanol to the mass of the composite tobacco flavor is: 50 ml/1 g.
11. The method of claim 1, wherein the composite tobacco flavor is a tobacco flavor-based module.
12. The method of claim 10, wherein the composite tobacco flavor is a tobacco flavor-based module.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210592242.9A CN115097020B (en) | 2022-05-27 | 2022-05-27 | Method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210592242.9A CN115097020B (en) | 2022-05-27 | 2022-05-27 | Method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115097020A CN115097020A (en) | 2022-09-23 |
CN115097020B true CN115097020B (en) | 2024-05-14 |
Family
ID=83289037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210592242.9A Active CN115097020B (en) | 2022-05-27 | 2022-05-27 | Method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115097020B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017207467A1 (en) * | 2016-05-30 | 2017-12-07 | Givaudan Sa | Method of resolving allergens in perfume ingredients |
CN107543875A (en) * | 2017-03-29 | 2018-01-05 | 中国检验检疫科学研究院 | The screening method of Nitrofuran antibiotics chemical risk material in a kind of washing product |
CN110174488A (en) * | 2019-06-10 | 2019-08-27 | 青岛农业大学 | A kind of Allergic skin test method in cosmetics |
CN111289657A (en) * | 2020-03-31 | 2020-06-16 | 中国烟草总公司郑州烟草研究院 | Method for detecting fruit flavor components in main stream smoke of cigarette |
-
2022
- 2022-05-27 CN CN202210592242.9A patent/CN115097020B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017207467A1 (en) * | 2016-05-30 | 2017-12-07 | Givaudan Sa | Method of resolving allergens in perfume ingredients |
CN107543875A (en) * | 2017-03-29 | 2018-01-05 | 中国检验检疫科学研究院 | The screening method of Nitrofuran antibiotics chemical risk material in a kind of washing product |
CN110174488A (en) * | 2019-06-10 | 2019-08-27 | 青岛农业大学 | A kind of Allergic skin test method in cosmetics |
CN111289657A (en) * | 2020-03-31 | 2020-06-16 | 中国烟草总公司郑州烟草研究院 | Method for detecting fruit flavor components in main stream smoke of cigarette |
Non-Patent Citations (1)
Title |
---|
超高效液相色谱-四极杆/静电场轨道阱高分辨质谱法快速筛查配制酒中的11种那非类药物;赵光升;郭立净;袁利杰;尹志威;姬建生;;中国卫生检验杂志;20191225(第24期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN115097020A (en) | 2022-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dong et al. | Gas chromatography–mass spectrometry of carbonyl compounds in cigarette mainstream smoke after derivatization with 2, 4-dinitrophenylhydrazine | |
CN107764917B (en) | Method for determining key volatile components in cigarette blasting beads | |
Li et al. | Detection and quantification of low-molecular-weight aldehydes in pharmaceutical excipients by headspace gas chromatography | |
CN110487924B (en) | Method for detecting cigarette perfuming uniformity based on additional marker | |
Feuerstein et al. | Novel acquisition strategies for metabolomics using drift tube ion mobility-quadrupole resolved all ions time-of-flight mass spectrometry (IM-QRAI-TOFMS) | |
JP4800048B2 (en) | Method for measuring isotope content | |
CN102230918A (en) | Method for determining benzene and benzene series contents in flavor and spices for cigarettes | |
CN109061017B (en) | Method for evaluating cigarette perfuming uniformity | |
CN110907565B (en) | Method for measuring carbonyl-containing aroma components in smoke of cigarette heated without combustion | |
Wang et al. | Qualitative analysis of flavors and fragrances added to tea by using GC–MS | |
CN111398487A (en) | Application method of retention index in gas chromatography-tandem mass spectrometry analysis of tobacco flavor components | |
CN110133155A (en) | A kind of gas chromatography tandem mass spectrometry analysis method of essence spice for cigarette | |
Zhang et al. | Simultaneous Determination of Four Aldehydes in Gas Phase of Mainstream Smoke by Headspace Gas Chromatography‐Mass Spectrometry | |
CN115097020B (en) | Method for screening and confirming composite tobacco flavor based on gas chromatography-quadrupole/electrostatic field orbit trap high-resolution mass spectrum | |
CN111208310B (en) | GC-QTOF detection method for aldehyde ketone fragrance components in tobacco and tobacco products | |
Saudan et al. | Carbon isotopic ratio analysis by gas chromatography/combustion/isotope ratio mass spectrometry for the detection of gamma‐hydroxybutyric acid (GHB) administration to humans | |
CN107490642A (en) | Method that is a kind of while determining 12 kinds of alkaloids in cigarette smoke granule phase substance | |
Pavón et al. | Headspace–programmed temperature vaporizer–fast gas chromatography–mass spectrometry coupling for the determination of trihalomethanes in water | |
Miller IV et al. | UHPLC separation with MS analysis for eight carbonyl compounds in mainstream tobacco smoke | |
CN111289657A (en) | Method for detecting fruit flavor components in main stream smoke of cigarette | |
Zhang et al. | Headspace Solid-Phase Microextraction Coupled with Gas Chromatography–Mass Spectrometry (HS-SPME-GC–MS) for the Characterization of Cigar Leaves | |
CN111983108B (en) | Chiral analysis method for main alkaloids in electronic smoke sol | |
CN110568101B (en) | Method for determining volatile and semi-volatile components in cut tobacco based on HS-SPME-GC-MS/MS | |
Luo et al. | Solid‐phase extraction of tobacco‐specific N‐nitrosamines with a mixed‐mode hydrophobic/cation‐exchange sorbent | |
CN107831228B (en) | Method and kit for determining citronellal in sample and application of kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |